640P Quality of life and survival in elderly metastatic castration-resistant prostate cancer (mCRPC) patients (Pts) treated with docetaxelIrene Paredero, A. Sánchez-Hernández, R. Lozano Mejorada et al.|Annals of Oncology|2020Cited by 1
Use of geriatric assessment (GA) in metastatic castration-resistant prostate cancer (MCRPC) in elderly cancer patients suitable for docetaxelRegina Gironés Sarrió, N. Gómez, S. Forcano et al.|Journal of Geriatric Oncology|2021Cited by 0